CQW Panacea-re-brand-rev3

For the Week of August 31, 2015

Question:

In its quarterly update to the outpatient PPS, did CMS add pass-through status for any new drugs?

Answer:

Effective July 1, 2015, the following three drugs and biologicals below have pass-through status under the hospital outpatient prospective payment system (OPPS).

C9453 Injection, nivolumab, 1 mg
C9454 Injection, pasireotide long acting, 1 mg
C9455 Injection, siltuximab, 10 mg

 

Return to Compliance Question of the Week Index

BMQ3PPMUE15

Sign up to receive Compliance Question of the Week.

To view and archive of the Pharmacy Compliance Question of the Week, click here